Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
Use this CDTX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the CDTX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the CDTX SEC filings page. Lician reads the product cache first so this HTML stays unique to Cidara Therapeutics Inc even when a live quote feed is slow.
Latest cached year on this hub. Full CDTX income, balance, and cash tables.